News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
1170
Sources here
11
Companies here
21
Search results Stored financial headlines

Active search

1170 matching headlines

Ticker or company: CITMain company stories
Clear
Latest

finance.yahoo.com Earnings

Citius Oncology shares tumble as Q3 revenue misses forecasts despite LYMPHIR launch momentum

Stock chart with numbers going down ©Shutterstock Citius Oncology Inc. (NASDAQ:CTOR) shares fell 10.05% in pre-market trading on Monday after the company reported fiscal third-quarter results that fell well short of analyst expectations, despite signs of increasing institutional demand for LYMPHIR. Quarterly revenue came in at $1.5 million, substantially below the consensus estimate of $12.52 million. Revenue nevertheless …

Citigroup names Adam Clark wealth planning head

Citigroup is bringing in Adam Clark to take charge of wealth planning, according to a memo seen by Private Banker International and confirmed by a spokesperson. He takes over from Mike Troth, who has been covering the job on an interim basis. In the …

C main company C main company CTGP34 main company C main company TRVC main company CITI main company
Sharemaestro market context Trend signal active 52 weeks +72.6% · Next-week setup positive 57.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Plato Investment Management Ltd Makes New $11.95 Million Investment in Citigroup Inc. $C

Plato Investment Management Ltd has made a new investment of $11.95 million in Citigroup Inc., purchasing 85,879 shares in the second quarter. This move makes Citigroup the 27th largest holding in Plato's portfolio, comprising 0.7% of their total investments. Institutional investors now collectively own …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Diamond Hill Capital Management LLC Investment Advisor Invests $52.94 Million in Citigroup Inc. $C

Diamond Hill Capital Management LLC Investment Advisor recently acquired a new stake in Citigroup Inc. (NYSE:C) during the second quarter, purchasing 378,238 shares valued at approximately $52.94 million. Other institutional investors have also adjusted their holdings in Citigroup, reflecting varied sentiment. The article details …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citius Pharmaceuticals GAAP EPS of -$0.34 misses by $0.09, revenue of $1.5M misses by $8.27M

* Citius Pharmaceuticals press release [https://seekingalpha.com/pr/20620155-citius-pharmaceuticals-inc-reports-fiscal-third-quarter-2026-financial-results-and-provides] (CTXR [https://seekingalpha.com/symbol/CTXR]): Q3 GAAP EPS of -$0.34 misses by $0.09. * Revenue of $1.5M misses by $8.27M. * Cash and cash equivalents of $17.0 million as of June 30, 2026. MORE ON CITIUS PHARMACEUTICALS * Seeking Alpha’s Quant …

CTXR main company
Sharemaestro market context Price above Trend Line 52 weeks -44.0% · Next-week setup negative 40.1% CTXR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

3 Reasons to Sell PCTY and 1 Stock to Buy Instead

3 Reasons to Sell PCTY and 1 Stock to Buy Instead What a time it's been for Paylocity. In the past six months alone, the company's stock price has increased by a massive 41.8%, reaching $152.67 per share. This was partly thanks to its …

PCTY main company
Sharemaestro market context Trend signal active 52 weeks -18.7% PCTY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

S&CO Inc. Buys New Shares in Citigroup Inc. $C

S&CO Inc. has acquired 39,794 shares of Citigroup Inc. (NYSE:C) in the second quarter, valued at approximately $5.57 million, increasing institutional ownership to 71.72%. Citigroup recently reported strong quarterly earnings, beating estimates with an EPS of $3.15 and revenue of $24.77 billion, and authorized …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Paylocity director Steven Sarowitz sells $1.68m of stock By Investing.com

Paylocity director Steven I. Sarowitz sold approximately $1.68 million worth of the company's common stock on August 6, 2026, through a pre-arranged trading plan. Despite this insider sale, Paylocity's stock has performed strongly, returning 38% in the past six months, and is considered undervalued …

PCTY main company
Sharemaestro market context Trend signal active 52 weeks -18.7% PCTY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citius Pharmaceuticals Reports LYMPHIR Revenue Growth, Explores CAR-T Combination

Citius Pharmaceuticals reported promising early results for its approved drug LYMPHIR in new indications, including an 86% objective response rate in a Phase 1 CAR-T combination trial for diffuse large B-cell lymphoma and a 24% ORR in gynecologic malignancies. The company also announced strong …

CTXR main company
Sharemaestro market context Price above Trend Line 52 weeks -44.0% · Next-week setup negative 40.1% CTXR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Has Cintas Stock Slipped Despite Record Margins? What to Know Amid a Founder's Vesting

Executive Chairman Scott D. Farmer disposed of 15,923 shares of Cintas Corporation (NASDAQ:CTAS) at $202.71 per share on August 10, according to a recent SEC Form 4 filing. Transaction summary Metric Value Shares sold (direct) 15,923 Transaction value $3.2 million Post-transaction shares (directly held) …

CIT main company
Sharemaestro market context Trend signal started 51 weeks -56.5% · Next-week setup positive 57.5% CIT stored weekly price path from 8 Aug 2025 to 14 Aug 2026

What a Cintas CEO Insider Filing Signals as It Pursues UniFirst

Todd M. Schneider, the CEO of Cintas Corporation (NASDAQ:CTAS), disposed of 35,599 shares of common stock on August 10, according to an SEC Form 4 filing. Transaction summary Metric Value Shares sold 35,599 Transaction value $7.2 million Post-transaction shares (directly held) 691,407 Post-transaction shares …

CIT main company
Sharemaestro market context Trend signal started 51 weeks -56.5% · Next-week setup positive 57.5% CIT stored weekly price path from 8 Aug 2025 to 14 Aug 2026

Diversified Banks Stocks Q2 Earnings: Citigroup (NYSE:C) Firing on All Cylinders

Diversified Banks Stocks Q2 Earnings: Citigroup (NYSE:C) Firing on All Cylinders As the Q2 earnings season comes to a close, it's time to take stock of this quarter's best and worst performers in the diversified banks industry, including Citigroup (NYSE:C) and its peers. At …

C main company C main company CTGP34 main company C main company TRVC main company CITI main company
Sharemaestro market context Trend signal active 52 weeks +72.6% · Next-week setup positive 57.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citizens, Inc. president & CEO Jon Stenberg buys $43,795 in stock

Citizens, Inc. President and CEO Jon Stenberg recently purchased 12,000 shares of the company's Class A Common Stock for $43,795, reflecting increased executive ownership. This transaction occurred on August 11, 2026, with shares bought at $3.6496 each, near its 52-week low. InvestingPro analysis suggests …

CIA main company
Sharemaestro market context Price below Trend Line 52 weeks -25.8% CIA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Breakeven On The Horizon For Citius Oncology, Inc. (NASDAQ:CTOR)

Citius Oncology, Inc. (NASDAQ:CTOR) is anticipated to reach profitability by 2027, according to analysts, after posting a significant loss in its most recent financial year. The company is projected to achieve a profit of US$12 million in 2027, driven by an estimated annual growth …

CTOR main company
Sharemaestro market context Price above Trend Line 52 weeks -48.0% CTOR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LRZ Capital LLC Decreases Position in Canadian Pacific Kansas City Limited $CP

LRZ Capital LLC reduced its stake in Canadian Pacific Kansas City Limited ($CP) by 11.7% in the second quarter, selling 17,255 shares but still holding 130,750 shares valued at approximately $11.3 million. Despite this reduction, Canadian Pacific Kansas City remains the 8th largest holding …

CP main company CP main company
Sharemaestro market context Trend signal active 52 weeks +26.2% CP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Canadian Pacific Kansas City Limited $CP Shares Acquired by Vontobel Holding Ltd.

Vontobel Holding Ltd. significantly increased its stake in Canadian Pacific Kansas City (CP) by 12,903% in the second quarter, acquiring 874,710 shares valued at approximately $75.8 million. Analysts maintain a "Moderate Buy" rating for CP, with a consensus price target of $108.60, following recent …

CP main company
Sharemaestro market context Trend signal active 52 weeks +26.1% CP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citizens & Northern (NASDAQ:CZNC) Upgraded to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded Citizens & Northern (NASDAQ:CZNC) to a "strong-buy" rating. This follows other upgrades from Weiss Ratings and Zacks Research, although the overall analyst consensus remains "Hold" with a $23.50 target price. The company recently reported strong quarterly earnings of $0.79 per …

CZNC main company
Sharemaestro market context Trend signal active 52 weeks +31.9% CZNC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citizens & Northern (NASDAQ:CZNC) Stock Passes Above 200-Day Moving Average - Should You Sell?

Citizens & Northern (NASDAQ:CZNC) stock recently surpassed its 200-day moving average, trading as high as $26.25, significantly above its long-term average of $22.76. Despite improved analyst sentiment and recent upgrades, the consensus rating remains "Hold" with a target price below the current share price. …

CZNC main company
Sharemaestro market context Trend signal active 52 weeks +31.9% CZNC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Studio City International (NYSE: MSC) Q2 2026 revenue slips to $164.6M, loss widens

Studio City International Holdings Limited reported a decline in Q2 2026 total operating revenues to $164.6 million from $190.1 million in Q2 2025, primarily due to weaker mass market table games performance and lower non-gaming revenues. The company's net loss widened to $15.6 million …

MSC main company
Sharemaestro market context Price below Trend Line 52 weeks -62.2% · Next-week setup negative 44.2% MSC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citigroup Global Markets (GSAT) schedules NASDAQ sale of 24,100 common shares

Citigroup Global Markets Inc. has filed to sell up to 24,100 common shares of Globalstar, Inc. (GSAT) on NASDAQ, with an aggregate market value of $1,980,352.43. The sale is scheduled for on or after August 14, 2026. The filing also details prior restricted stock …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citius Oncology (NASDAQ:CTOR) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Citius Oncology (NASDAQ:CTOR) reported its quarterly earnings, missing analyst expectations with an EPS loss of $0.08 against an estimated $0.07, and revenue of $1.49 million, below the $2.50 million estimate. Despite the misses, the stock price rose 10% to $0.91 on Friday with double …

CTOR main company
Sharemaestro market context Price above Trend Line 52 weeks -48.0% CTOR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citigroup (C) Agrees To Acquire A Rewards Startup

Citigroup (NYSE:C) is set to acquire rewards startup Kard Financial to enhance its consumer engagement capabilities. Concurrently, Citi is involved in financing major U.S. power infrastructure projects, aligning its strategy with both next-generation consumer rewards and large-scale infrastructure finance. These initiatives support Citi's focus …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citius Pharmaceuticals Reports Q3 2026 Financial Results and LYMPHIR Progress

Citius Pharmaceuticals reported strong Q3 2026 financial results, including $7.1 million in commercial sales revenue for the first nine months of the fiscal year and $17 million in cash reserves. The company highlighted significant progress with its lead product, LYMPHIR, noting an 86% objective …

CTXR main company
Sharemaestro market context Price above Trend Line 52 weeks -44.0% · Next-week setup negative 40.1% CTXR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context